CTOs on the Move

BBK Worldwide

www.bbkweb.com

 
BBK Worldwide is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.bbkweb.com
  • 320 Needham St
    Newton, MA USA 02464
  • Phone: 617.630.4477

Executives

Name Title Contact Details

Similar Companies

FCB Health

With more than 30 years of experience marketing to healthcare professionals, patients, and consumers, FCB Health produces work that is both strategically relevant and creatively compelling. We provide clients with multichannel capabilities, including payer strategy and marketing, professional education, video production, strategic planning, and media services.

NeuroFlow

There is a health crisis in America. In every community, 1 in 4 people live with mental health disorders and the demand for behavioral health services has been amplified in the wake of COVID-19. Social isolation, economic downturns, and tense conditions have amplified the effects of depression, anxiety, and substance use disorder.

THC

THC.com is the safe place to connect about all things cannabis. THC.com is social media that supports YOU. Get paid on product endoresments!

Caresouth Homecare Professionals, Inc.

CareSouth is one of the country's leading providers of home health care services. The Company's corporate headquarters is located in Augusta, Georgia and includes a large data processing and financial services center.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.